Breaking News Instant updates and real-time market news.

AET

Aetna

$141.36

1.13 (0.81%)

16:51
05/19/17
05/19
16:51
05/19/17
16:51

Aetna sees affirming FY17 adjusted EPS view of $8.80-$9.00, consensus $8.96

According to a regulatory filing, Aetna said that chairman and CEO Mark T. Bertolini and other management will meet with investors and analysts on May 22 before and after a presentation Mr. Bertolini will provide at the UBS Global Healthcare Conference 2017 in New York, New York. During the presentation and meetings, the company expects to reaffirm our full-year 2017 net income per share projection of $4.48 to $4.68 and our full-year 2017 adjusted earnings per share projection of $8.80 to $9.00.

  • 19

    May

AET Aetna
$141.36

1.13 (0.81%)

05/05/17
LEER
05/05/17
NO CHANGE
Target $90
LEER
Outperform
CVS Health should retain Aetna, says Leerink
Leerink analyst David Larsen remains positive on CVS Health (CVS) following the company's earnings call. The analyst believes that as investors look to 2018, CVS will have major headwinds behind it, including volume loss from narrow networks and promotion rationalization in retail. Larsen sees a "significant positive catalyst" in a potential Anthem (ANTM) win later this year, and does not believe there is real risk to the Aetna (AET) business. He reiterates an Outperform rating and $90 price target on CVS' shares.
05/11/17
CLVD
05/11/17
UPGRADE
CLVD
Buy
Aetna upgraded to Buy from Neutral at Cleveland Research
Cleveland Research analyst Steve Willoughby upgraded Aetna (AET) to Buy saying recent research indicates an expanding relationship with CVS likely beginning on January 1, 2018. The analyst believes an enhanced partnership with CVS will generate significant savings for Aetna and support stronger 2018 MA growth, on top of additional earnings growth of 2-7%.
05/15/17
FBCO
05/15/17
NO CHANGE
Target $155
FBCO
Outperform
Aetna price target raised to $155 from $150 at Credit Suisse
Credit Suisse analyst Scott Fidel raised his price target for Aetna (AET) to $155 from $150 after the company updated investors on its long-term strategy post the demise of the Humana (HUM) merger. The strategy still includes an intense focus on Medicare Advantage as the key future growth driver, with the company also making it clear that it does not intend to deploy much capital to acquire direct physician and other provider assets. The analyst reiterates an Outperform rating on the shares.
05/15/17
UBSW
05/15/17
NO CHANGE
Target $160
UBSW
Buy
Aetna price target raised to $160 from $147 at UBS
UBS analyst A. J. Rice raised his price target on Aetna to $160 from $147 following its bullish investor update meeting. The company believes long-term earnings will grow in the low double digit range, driven by organic earnings growth and capital deployment, noted Rice, who reiterated his Outperform rating on Aetna shares.

TODAY'S FREE FLY STORIES

BIIB

Biogen

$284.70

1.78 (0.63%)

06:31
07/25/17
07/25
06:31
07/25/17
06:31
Earnings
Biogen reports Q2 adjusted EPS $5.04, consensus $4.41 »

Reports Q2 revenue $3.1B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 01

    Aug

GOOG

Alphabet

$980.34

7.42 (0.76%)

, GOOGL

Alphabet Class A

$998.31

4.47 (0.45%)

06:30
07/25/17
07/25
06:30
07/25/17
06:30
Recommendations
Alphabet, Alphabet Class A analyst commentary  »

Alphabet earnings…

GOOG

Alphabet

$980.34

7.42 (0.76%)

GOOGL

Alphabet Class A

$998.31

4.47 (0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLY

Eli Lilly

$84.74

0.08 (0.09%)

06:30
07/25/17
07/25
06:30
07/25/17
06:30
Hot Stocks
Eli Lilly will pursue new standard-of-care changing therapies in oncology »

Eli Lilly is providing an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 11

    Sep

LLY

Eli Lilly

$84.74

0.08 (0.09%)

06:29
07/25/17
07/25
06:29
07/25/17
06:29
Earnings
Eli Lilly raises FY17 EPS view to $4.10-$4.20 from $4.05-$4.15, consensus $4.12 »

Raises FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 11

    Sep

DDAIF

Daimler AG

$71.00

-1.9399 (-2.66%)

, BMWYY

BMW

$30.72

-0.8 (-2.54%)

06:28
07/25/17
07/25
06:28
07/25/17
06:28
Periodicals
Daimler directors to discuss alleged German auto cartel, Reuters says »

Daimler's (DDAIF)…

DDAIF

Daimler AG

$71.00

-1.9399 (-2.66%)

BMWYY

BMW

$30.72

-0.8 (-2.54%)

VLKAY

Volkswagen

$32.19

-0.79 (-2.40%)

POAHY

Porsche

$5.82

-0.03 (-0.51%)

AUDVF

Audi AG

$835.60

-4.8 (-0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WERN

Werner

$29.20

-0.35 (-1.18%)

06:28
07/25/17
07/25
06:28
07/25/17
06:28
Upgrade
Werner rating change  »

Werner upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

TNTR

Tintri

$6.95

0.16 (2.36%)

06:28
07/25/17
07/25
06:28
07/25/17
06:28
Initiation
Tintri initiated  »

Tintri initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BY

Byline Bancorp

$20.85

0.13 (0.63%)

06:28
07/25/17
07/25
06:28
07/25/17
06:28
Initiation
Byline Bancorp initiated  »

Byline Bancorp initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jul

LLY

Eli Lilly

$84.74

0.08 (0.09%)

06:26
07/25/17
07/25
06:26
07/25/17
06:26
Earnings
Eli Lilly reports Q2 EPS $1.11, consensus $1.05 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 11

    Sep

NCMGY

Newcrest Mining

$15.72

0.12 (0.77%)

06:26
07/25/17
07/25
06:26
07/25/17
06:26
Upgrade
Newcrest Mining rating change  »

Newcrest Mining upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPNC

Spectranetics

$38.50

0.05 (0.13%)

06:21
07/25/17
07/25
06:21
07/25/17
06:21
Downgrade
Spectranetics rating change  »

Spectranetics downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMP

Tompkins Financial

$78.41

-0.14 (-0.18%)

06:21
07/25/17
07/25
06:21
07/25/17
06:21
Upgrade
Tompkins Financial rating change  »

Tompkins Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNE

Sony

$40.61

-0.2 (-0.49%)

, AAPL

Apple

$152.09

1.82 (1.21%)

06:20
07/25/17
07/25
06:20
07/25/17
06:20
Periodicals
Sony restructures television production unit, WSJ reports »

Sony Pictures…

SNE

Sony

$40.61

-0.2 (-0.49%)

AAPL

Apple

$152.09

1.82 (1.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

LLY

Eli Lilly

$84.74

0.08 (0.09%)

, INCY

Incyte

$138.27

4.05 (3.02%)

06:20
07/25/17
07/25
06:20
07/25/17
06:20
Hot Stocks
Eli Lilly, Incyte resubmit baricitinib NDA to FDA »

Eli Lilly (LLY) and…

LLY

Eli Lilly

$84.74

0.08 (0.09%)

INCY

Incyte

$138.27

4.05 (3.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 01

    Aug

  • 11

    Sep

SSB

South State

$83.90

0.7 (0.84%)

06:19
07/25/17
07/25
06:19
07/25/17
06:19
Upgrade
South State rating change  »

South State upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 18

    Sep

BSRR

Sierra Bancorp

$24.15

0.34 (1.43%)

06:19
07/25/17
07/25
06:19
07/25/17
06:19
Upgrade
Sierra Bancorp rating change  »

Sierra Bancorp upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

BY

Byline Bancorp

$20.85

0.13 (0.63%)

06:17
07/25/17
07/25
06:17
07/25/17
06:17
Initiation
Byline Bancorp initiated  »

Byline Bancorp initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jul

GOOGL

Alphabet Class A

$998.31

4.47 (0.45%)

, GOOG

Alphabet

$980.34

7.42 (0.76%)

06:16
07/25/17
07/25
06:16
07/25/17
06:16
Recommendations
Alphabet Class A, Alphabet analyst commentary  »

Alphabet post-earnings…

GOOGL

Alphabet Class A

$998.31

4.47 (0.45%)

GOOG

Alphabet

$980.34

7.42 (0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LULU

lululemon

$62.02

0.08 (0.13%)

06:16
07/25/17
07/25
06:16
07/25/17
06:16
Downgrade
lululemon rating change  »

lululemon downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

WBMD

WebMD

$66.10

10.91 (19.77%)

06:14
07/25/17
07/25
06:14
07/25/17
06:14
Downgrade
WebMD rating change  »

WebMD downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WBMD

WebMD

$66.10

10.91 (19.77%)

06:13
07/25/17
07/25
06:13
07/25/17
06:13
Downgrade
WebMD rating change  »

WebMD downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BKS

Barnes & Noble

$7.10

-0.05 (-0.70%)

06:12
07/25/17
07/25
06:12
07/25/17
06:12
Periodicals
Activist investor Sandell urges Barnes & Noble to sell, WSJ reports »

Sandell Asset Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKZOY

AkzoNobel

$29.20

-0.45 (-1.52%)

06:12
07/25/17
07/25
06:12
07/25/17
06:12
Hot Stocks
Breaking Hot Stocks news story on AkzoNobel »

AkzoNobel says to hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKZOY

AkzoNobel

$29.20

-0.45 (-1.52%)

06:11
07/25/17
07/25
06:11
07/25/17
06:11
Hot Stocks
Breaking Hot Stocks news story on AkzoNobel »

AkzoNobel creating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKZOY

AkzoNobel

$29.20

-0.45 (-1.52%)

06:11
07/25/17
07/25
06:11
07/25/17
06:11
Hot Stocks
Breaking Hot Stocks news story on AkzoNobel »

AkzoNobel supervisory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.